Table 6 Outcomes respective of new intracranial pathology.

From: The serum biomarkers NSE and S100B predict intracranial complications and in-hospital survival in patients undergoing veno-venous ECMO

Label

Metric

New intracranial pathology

p-value

No

Yes

Length of stay

Median[IQR]

28.6 [15.8;53.9]

23.9 [14.3;42.6]

ns

ICU length of stay

Median[IQR]

26.7 [13.9;48.5]

23.1 [13.5;41.7]

ns

Death

Yes

213 (63%)

70 (80%)

0.0034

in-hospital death

Yes

188 (56%)

68 (77%)

0.0002

days of survival

Median[IQR]

38.0 [14.0;432.0]

24.5 [11.8;55.0]

0.0136